Advanced Design Methods towards the Combination of Additively Manufactured Scaffolds and Drug Delivery in Pharmaceutics

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".

Deadline for manuscript submissions: closed (10 February 2023) | Viewed by 4010

Special Issue Editors


E-Mail Website
Guest Editor
Department of Industrial Engineering, Fraunhofer JL IDEAS-University of Naples Federico II, P.le Tecchio 80, 80125 Naples, Italy
Interests: design for additive manufacturing; reverse engineering; design methods; creative design; mechanical analysis; modeling and simulation; biomechanics; scaffold design
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Regenerative engineering represents a field involving the design of biodegradable three-dimensional (3D) structures (i.e., scaffolds) with cells and tissue-inducing factors. Mechanical engineering, materials science, biology, biotechnology, and translational medicine are generally integrated to design 3D constructs for tissue engineering.

3D scaffolds may act as carriers for several kinds of drugs and genes, and the release profile may be finely tuned according to the composition, porosity, and geometrical features of the designed structures.

Over the past few years, the combination of growth factors and 3D scaffolds has been frequently proposed to develop advanced systems, which are able to function as biodegradable supports for tissue growth, also allowing the exploration of biological signals to modulate tissue regeneration.

Specific drugs, growth factors, and biomolecules can be incorporated into 3D scaffolds using several strategies.

In this scenario, additive manufacturing allows the development of 3D scaffolds with an interconnected pore network, well-defined geometries and pore shape and size, as well as with tailored mechanical and mass transport properties. The creative design of scaffolds involves novel and creative engineering techniques for systematically generating all possible design configurations, in order to meet design requirements and constraints.

Accordingly, it is through the combination of additively manufactured scaffolds and drug delivery that the current Special Issue is aimed at presenting criteria and methods for the design of advanced systems in pharmaceutics.

This approach would offer new possibilities for the design of biomimetic systems with specific hierarchical architectures and tunable release kinetics.

For this reason, in the present Special Issue, we invite authors to submit papers with the aim of providing a complete view of the current progresses.

Potential topics include but are not limited to the following:

  • Design for additive manufacturing;
  • Scaffold design;
  • Design methods;
  • Design for drug delivery;
  • Release profile;
  • Conceptual and creative design;
  • Design of experiments;
  • Lattice structures;
  • Biomimetics;
  • Topology optimization;
  • Additive manufacturing;
  • Computer-aided design;
  • Finite element analysis.

Prof. Dr. Antonio Gloria
Prof. Dr. Massimo Martorelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 4271 KiB  
Article
Development and In Vitro Evaluation of 5-Fluorouracil-Eluting Stents for the Treatment of Colorectal Cancer and Cancer-Related Obstruction
by Mohammad Arafat, Paris Fouladian, Anthony Wignall, Yunmei Song, Ankit Parikh, Hugo Albrecht, Clive A. Prestidge, Sanjay Garg and Anton Blencowe
Pharmaceutics 2021, 13(1), 17; https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics13010017 - 24 Dec 2020
Cited by 16 | Viewed by 3412
Abstract
Self-expanding metal stents (SEMSs) are currently the gold standard for the localised management of malignant gastrointestinal (GI) stenosis and/or obstructions. Despite encouraging clinical success, in-stent restenosis caused by tumour growth is a significant challenge. Incorporating chemotherapeutic drugs into GI stents is an emerging [...] Read more.
Self-expanding metal stents (SEMSs) are currently the gold standard for the localised management of malignant gastrointestinal (GI) stenosis and/or obstructions. Despite encouraging clinical success, in-stent restenosis caused by tumour growth is a significant challenge. Incorporating chemotherapeutic drugs into GI stents is an emerging strategy to provide localised and sustained release of drugs to intestinal malignant tissues to prevent tumour growth. Therefore, the aim of this work was to develop and evaluate a local GI stent-based delivery system that provides a controlled release of 5-fluorouracil (5FU) over a course of several weeks to months, for the treatment of colorectal cancer and cancer-related stenosis/obstructions. The 5FU-loaded GI stents were fabricated via sequential dip-coating of commercial GI stents with a drug-loaded polyurethane (PU) basecoat and a drug-free poly(ethylene-co-vinyl acetate) (PEVA) topcoat. For comparison, two types of commercial stents were investigated, including bare and silicone (Si) membrane-covered stents. The physicochemical properties of the 5FU-loaded stents were evaluated using photoacoustic Fourier-transform infrared (PA-FTIR) spectroscopy, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), and thermal analysis. In vitro release studies in biological medium revealed that the 5FU-loaded stents provided a sustained release of drug over the period studied (18 d), and cell viability, cell cycle distribution and apoptosis assays showed that the released 5FU had comparable anticancer activity against human colon cancer cells (HCT-116) to pure 5FU. This study demonstrates that dip-coating is a facile and reliable approach for fabricating drug-eluting stents (DESs) that are promising candidates for the treatment of GI obstructions and/or restenosis. Full article
Show Figures

Figure 1

Back to TopTop